Symbol="KROS"
AssetType="Common Stock"
Name="Keros TherapeuticsÂ Inc"
Description="Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with a great unmet medical need. The company is headquartered in Lexington, Massachusetts."
CIK="1664710"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="99 HAYDEN AVENUE, SUITE 120 (BLD E), LEDGEMONT TECHNOLOGY CENTER, LEXINGTON, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="1241649000"
EBITDA="-128805000"
PERatio="None"
PEGRatio="None"
BookValue="12.01"
DividendPerShare="0"
DividendYield="0"
EPS="-4.43"
RevenuePerShareTTM="0.824"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.261"
ReturnOnEquityTTM="-0.402"
RevenueTTM="20000000"
GrossProfitTTM="-87265000"
DilutedEPSTTM="-4.43"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="90.71"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="68.42"
PriceToBookRatio="5.74"
EVToRevenue="57.24"
EVToEBITDA="-14.45"
Beta="1.084"
num_52WeekHigh="59.96"
num_52WeekLow="29.33"
num_50DayMovingAverage="43.27"
num_200DayMovingAverage="46.64"
SharesOutstanding="29584200"
DividendDate="None"
ExDividendDate="None"
symbol="KROS"
open="39.51"
high="42.38"
low="39.51"
price="41.97"
volume="369335.00"
latest_trading_day="2023-07-28"
previous_close="39.26"
change="2.71"
change_percent="6.9027%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="88"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="12"
Volume_recent_avg="222695"
Change_recent_avg="-0.1"
Delta_recent_avg="2.28"
Variance_recent_avg="1.14"
Change_ratio_recent_avg="-0.27"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="12"
Aroon_momentum_negative="88"
image_negative_thumbnail_id_1="514"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0091.jpeg"
image_negative_thumbnail_id_2="108"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0068.jpeg"
image_neutral_thumbnail_id_1="568"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0031.jpeg"
image_neutral_thumbnail_id_2="562"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0037.jpeg"
image_positive_thumbnail_id_1="621"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0087.jpeg"
image_positive_thumbnail_id_2="1000"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0162.jpeg"
image_professor_thumbnail_id_1="1200"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0034.jpeg"
image_professor_thumbnail_id_2="1197"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0031.jpeg"
